Schaper Benz & Wise Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,439
| Closed | -$220K | – | 134 |
|
|
2023
Q2 | $220K | Buy |
3,439
+201
| +6% | +$13.5K | 0.02% | 130 |
|
|
2023
Q1 | $224K | Sell |
3,238
-47
| -1% | -$3.31K | 0.02% | 132 |
|
|
2022
Q4 | $236K | Hold |
3,285
| – | – | 0.03% | 126 |
|
|
2022
Q3 | $234K | Sell |
3,285
-1,263
| -28% | -$91.6K | 0.03% | 129 |
|
|
2022
Q2 | $350K | Hold |
4,548
| – | – | 0.04% | 117 |
|
|
2022
Q1 | $332K | Buy |
4,548
+1,263
| +38% | +$84.8K | 0.03% | 125 |
|
|
2021
Q4 | $205K | Buy |
+3,285
| New | +$193K | 0.02% | 146 |
|
|
2021
Q3 | – | Sell |
-3,285
| Closed | -$220K | – | 128 |
|
|
2021
Q2 | $220K | Hold |
3,285
| – | – | 0.02% | 121 |
|
|
2021
Q1 | $207K | Hold |
3,285
| – | – | 0.02% | 121 |
|
|
2020
Q4 | $204K | Buy |
+3,285
| New | +$202K | 0.02% | 120 |
|
|
2020
Q1 | – | Sell |
-3,338
| Closed | -$214K | – | 107 |
|
|
2019
Q4 | $214K | Buy |
+3,338
| New | +$191K | 0.03% | 107 |
|
|
2018
Q4 | – | Sell |
-3,348
| Closed | -$208K | – | 106 |
|
|
2018
Q3 | $208K | Buy |
+3,348
| New | +$199K | 0.03% | 103 |
|
|
2018
Q2 | – | Sell |
-3,348
| Closed | -$212K | – | 104 |
|
|
2018
Q1 | $212K | Hold |
3,348
| – | – | 0.03% | 101 |
|
|
2017
Q4 | $205K | Hold |
3,348
| – | – | 0.03% | 103 |
|
|
2017
Q3 | $213K | Buy |
+3,348
| New | +$195K | 0.03% | 101 |
|
|
2016
Q3 | – | Sell |
-3,300
| Closed | -$243K | – | 101 |
|
|
2016
Q2 | $243K | Hold |
3,300
| – | – | 0.04% | 95 |
|
|
2016
Q1 | $211K | Hold |
3,300
| – | – | 0.04% | 97 |
|
|
2015
Q4 | $227K | Buy |
+3,300
| New | +$218K | 0.04% | 92 |
|
|
2015
Q3 | – | Sell |
-3,300
| Closed | -$220K | – | 97 |
|
|
2015
Q2 | $220K | Hold |
3,300
| – | – | 0.04% | 93 |
|
|
2015
Q1 | $213K | Sell |
3,300
-220
| -6% | -$13.8K | 0.04% | 93 |
|
|
2014
Q4 | $208K | Buy |
+3,520
| New | +$199K | 0.04% | 93 |
|
|
2014
Q2 | – | Sell |
-4,520
| Closed | -$235K | – | 93 |
|
|
2014
Q1 | $235K | Hold |
4,520
| – | – | 0.05% | 86 |
|
|
2013
Q4 | $240K | Sell |
4,520
-300
| -6% | -$15.3K | 0.05% | 88 |
|
|
2013
Q3 | $223K | Sell |
4,820
-300
| -6% | -$13.2K | 0.05% | 86 |
|
|
2013
Q2 | $229K | Buy |
+5,120
| New | +$222K | 0.06% | 81 |
|
Other funds holding BMY
Schaper Benz & Wise Investment Counsel's BMY Position: Q3 2023 in Review
Schaper Benz & Wise Investment Counsel sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 3,439 shares — an estimated $220K sold.
Schaper Benz & Wise Investment Counsel first reported a position in BMY in Q2 2013 and held it in 25 quarters. The position peaked at $350K in Q2 2022. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.
- Schaper Benz & Wise Investment Counsel reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
- Schaper Benz & Wise Investment Counsel sold 3,439 Bristol-Myers Squibb shares in Q3 2023, an estimated $220K.
- Schaper Benz & Wise Investment Counsel first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 25 quarters.
- Schaper Benz & Wise Investment Counsel's Bristol-Myers Squibb position peaked at $350K in Q2 2022.
- 2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.
Based on Schaper Benz & Wise Investment Counsel's 13F filing for Q3 2023, filed 11 Oct 2023.